|
CN104965041A
|
|
High performance liquid chromatography detection method for parecoxib sodium isomer
|
|
CN104897833A
|
|
Detection method for macitentan intermediate and application thereof
|
|
CN104557755A
|
|
Synthesis method for parecoxib sodium impurity
|
|
CN104557756A
|
|
Synthetic method of parecoxib sodium impurity
|
|
CN104592141A
|
|
Synthesis method of parecoxib sodium
|
|
CN104592142A
|
|
Synthesis method of parecoxib sodium impurity
|
|
CN104592140A
|
|
Synthesis method of parecoxib sodium impurity
|
|
CN104592139A
|
|
Synthetic method of impurity H of parecoxib sodium
|
|
CN104557754A
|
|
Synthesis method for parecoxib sodium impurity
|
|
CN104945343A
|
|
Synthesis method of parecoxib sodium impurity
|
|
CN104297365A
|
|
Determination method for residual solvent acetic acid in moxifloxacin hydrochloride
|
|
CN104095823A
|
|
Method for preparing Apixaban tablets
|
|
CN104045596A
|
|
Novel method for preparing etoricoxib intermediate 1-(6-methylpyridyl-3-yl)-2-[4-(mesyl)-phenyl]-ethyl-one
|
|
CN104031043A
|
|
Novel synthesis method of moxifloxacin hydrochloride
|
|
CN104031078A
|
|
Synthesis method of moxifloxacin hydrochloride intermediate
|
|
CN103819411A
|
|
New preparation method of macitentan intermediate
|
